Genmab A/S (NASDAQ:GMAB) Raised to Outperform at William Blair

Genmab A/S (NASDAQ:GMAB – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday, Marketbeat reports. William Blair also issued estimates for Genmab A/S’s FY2028 earnings at $4.06 EPS. A number of other brokerages have also weighed in on GMAB. […]

Mar 13, 2025 - 07:21
 0
Genmab A/S (NASDAQ:GMAB) Raised to Outperform at William Blair
Genmab A/S (NASDAQ:GMAB – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday, Marketbeat reports. William Blair also issued estimates for Genmab A/S’s FY2028 earnings at $4.06 EPS. A number of other brokerages have also weighed in on GMAB. […]